Biopharmaceutical researchers are developing more than 400 medicines for a wide range of neurological disorders, including disorders of the brain, spinal cord and nerves. Learn more in the Medicines in Development report.
There are more than 2,000 clinical trials listed in the National Institutes of Health database – for neurological disorders, such as Alzheimer’s disease, brain tumors, chronic pain, epilepsy, headache, multiple sclerosis and Parkinson’s disease.
America’s biopharmaceutical research companies are currently developing 420 medicines for patients suffering from neurological disorders, including epilepsy, Alzheimer’s disease, multiple sclerosis (MS) and Parkinson’s disease.
America’s biopharmaceutical research companies are developing 444 new medicines to prevent and treat neurological disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).